UTHR - UNITED THERAPEUTICS Corp
478.16
-6.900 -1.443%
Share volume: 315,914
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$485.06
-6.90
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2024 | 07-31-2024 | 10-30-2024 | 02-26-2025 | 04-30-2025 | 07-30-2025 | 10-29-2025 | 02-25-2026 | |
| Assets | |||||||||
| Total Assets | 6.495 B | 6.723 B | 7.123 B | 7.364 B | 7.744 B | 7.908 B | 7.351 B | 7.880 B | |
| Current Assets | 3.249 B | 3.620 B | 4.000 B | 3.874 B | 3.940 B | 3.827 B | 3.494 B | 3.703 B | |
| Inventories | 120.200 M | 136.500 M | 146.700 M | 157.900 M | 165.400 M | 169.200 M | 176.500 M | 183.100 M | |
| Other Current Assets | 113.400 M | 220.800 M | 185.400 M | 169.700 M | 131.100 M | 229.700 M | 252.200 M | 248.900 M | |
| Short Term Investments | 113.400 M | 220.800 M | 1.773 B | 1.570 B | 1.421 B | 1.456 B | 1.428 B | 1.363 B | |
| Total Receivables | 307.300 M | 290.700 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.708 B | 2.972 B | 1.554 B | 1.697 B | 1.900 B | 1.593 B | 1.340 B | 1.557 B | |
| Total Non-current Assets | 3.247 B | 3.104 B | 1.279 B | 1.475 B | 1.711 B | 1.918 B | 1.567 B | 1.777 B | |
| Property Plant Equipment | 1.074 B | 1.095 B | 1.157 B | 1.222 B | 1.303 B | 1.362 B | 1.556 B | 1.730 B | |
| Other Assets | 169.100 M | 167.900 M | 1.966 B | 2.268 B | 2.501 B | 2.719 B | 2.302 B | 2.448 B | |
| Intangible Assets | 115.400 M | 115.200 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 6.495 B | 6.723 B | 7.123 B | 7.364 B | 7.744 B | 7.908 B | 7.351 B | 7.880 B | |
| Total liabilities | 1.157 B | 1.026 B | 1.022 B | 920.000 M | 936.700 M | 734.400 M | 760.900 M | 783.800 M | |
| Total current liabilities | 860.600 M | 832.300 M | 873.400 M | 738.100 M | 721.500 M | 527.100 M | 546.300 M | 560.600 M | |
| Accounts Payable | 0.000 | 0.000 | 363.900 M | 344.500 M | 367.000 M | 432.000 M | 468.000 M | 488.000 M | |
| Other liabilities | 96.500 M | 93.700 M | 148.800 M | 181.900 M | 215.200 M | 207.300 M | 214.600 M | 223.200 M | |
| Current long term debt | 400.000 M | 400.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 200.000 M | 100.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 96.500 M | 93.700 M | 148.800 M | 181.900 M | 215.200 M | 207.300 M | 214.600 M | 223.200 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 5.338 B | 5.697 B | 6.101 B | 6.444 B | 6.807 B | 7.174 B | 6.590 B | 7.096 B | |
| Common stock | 47.000 M | 44.400 M | 2.648 B | 2.700 B | 2.739 B | 2.794 B | 2.660 B | 2.799 B | |
| Retained earnings | 6.334 B | 6.612 B | 6.921 B | 7.222 B | 7.544 B | 7.854 B | 8.193 B | 8.557 B |